Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07869394
PHASE4

Articaine Versus Lidocaine for Supplemental Buccal Infiltration in Lower First Molars With Irreversible Pulpitis

Sponsor: Rehman Medical Institute - RMI

View on ClinicalTrials.gov

Summary

Local anesthetic is used to numb a tooth before a root canal treatment. In lower back teeth with irreversible pulpitis (a painful, inflamed tooth nerve), the standard numbing injection near the jaw nerve, called an inferior alveolar nerve block, often does not numb the tooth enough. When this happens, patients may feel pain during treatment, and dentists often give an extra injection beside the tooth. This study compares two numbing medicines used for that extra injection: 4% articaine and 2% lidocaine, both with epinephrine. Articaine is a newer medicine that may pass through bone more easily, but it is not clear whether it works better than lidocaine in this situation. Adults aged 18 to 50 with a painful lower first molar needing a root canal first receive the standard nerve block with lidocaine. Patients who still feel pain when the dentist begins opening the tooth then receive an extra injection beside the tooth, with either articaine or lidocaine. Which medicine is given is decided by chance, and neither the patient nor the dentist knows which one it is.

Official title: Efficacy of Articaine Versus Lidocaine in Supplemental Infiltration for Mandibular First Molars With Symptomatic Irreversible Pulpitis After Failed Inferior Alveolar Nerve Block: A Prospective Randomized Double-Blind Clinical Trial

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2026-03-03

Completion Date

2026-08-27

Last Updated

2026-10-09

Healthy Volunteers

No

Interventions

DRUG

Articaine 4% with epinephrine 1:100,000

Supplemental buccal infiltration of 1.8 mL of 4% articaine with 1:100,000 epinephrine, given next to the mandibular first molar with a standard aspirating dental syringe and a 30-gauge short needle. It is given only to participants who report pain during access cavity preparation after an inferior alveolar nerve block with 2% lidocaine.

DRUG

Lidocaine 2% with Epinephrine 1:100,000

Supplemental buccal infiltration of 1.8 mL of 2% lidocaine with 1:100,000 epinephrine, given next to the mandibular first molar with a standard aspirating dental syringe and a 30-gauge short needle. It is given only to participants who report pain during access cavity preparation after an inferior alveolar nerve block with 2% lidocaine.

Locations (1)

Rehman Medical Institute

Peshawar, Pakistan